TY - JOUR
T1 - How SARS-CoV-2 Transformed the Clinical Laboratory
T2 - Challenges and Lessons Learned
AU - Tsai, Jonathan M.
AU - Tolan, Nicole V.
AU - Petrides, Athena K.
AU - Kanjilal, Sanjat
AU - Brigl, Manfred
AU - Lindeman, Neal I.
AU - Li, Yen Der
AU - Tanasijevic, Milenko J.
AU - Basu, Sankha S.
AU - Melanson, Stacy E.F.
N1 - Publisher Copyright:
© 2021 American Association for Clinical Chemistry. All rights reserved.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - The COVID-19 pandemic has made a devastating impact on global health and continues to challenge healthcare infrastructure and delivery. The clinical laboratories were no exception as they are responsible for diagnostic testing that dictates many clinical, infection control, and public health decisions. Information technology and laboratory management tools are critical assets for maintaining and adapting operations in response to crises. When utilized effectively, they promote the integration between the clinical laboratory specialties (e.g., chemistry, hematology, microbiology, and molecular pathology). During the COVID-19 pandemic, our systems and processes were strained due to high testing volumes, demand for rapid turnaround times, supply chain constraints, and constantly evolving testing algorithms and result interpretations as our knowledge of the virus and of diagnostics increased over time. In this report, we describe those challenges and subsequent adaptations made by each clinical laboratory section. We hope these details help to provide potential solutions and approaches for other hospitals facing COVID-19 surges or other future pandemics.
AB - The COVID-19 pandemic has made a devastating impact on global health and continues to challenge healthcare infrastructure and delivery. The clinical laboratories were no exception as they are responsible for diagnostic testing that dictates many clinical, infection control, and public health decisions. Information technology and laboratory management tools are critical assets for maintaining and adapting operations in response to crises. When utilized effectively, they promote the integration between the clinical laboratory specialties (e.g., chemistry, hematology, microbiology, and molecular pathology). During the COVID-19 pandemic, our systems and processes were strained due to high testing volumes, demand for rapid turnaround times, supply chain constraints, and constantly evolving testing algorithms and result interpretations as our knowledge of the virus and of diagnostics increased over time. In this report, we describe those challenges and subsequent adaptations made by each clinical laboratory section. We hope these details help to provide potential solutions and approaches for other hospitals facing COVID-19 surges or other future pandemics.
KW - clinical laboratory
KW - COVID-19
KW - informatics
KW - laboratory management
KW - lessons learned
KW - SARS-CoV-2 PCR testing
UR - https://www.scopus.com/pages/publications/85105747363
U2 - 10.1093/jalm/jfab034
DO - 10.1093/jalm/jfab034
M3 - Article
C2 - 33822967
AN - SCOPUS:85105747363
SN - 2576-9456
VL - 6
SP - 1338
EP - 1354
JO - Journal of Applied Laboratory Medicine
JF - Journal of Applied Laboratory Medicine
IS - 5
ER -